These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33746443)

  • 1. Ethnicity and Insurance-Specific Disparities in the Model for End-Stage Liver Disease Score at Time of Liver Transplant Waitlist Registration and its Impact on Mortality.
    Robinson A; Hirode G; Wong RJ
    J Clin Exp Hepatol; 2021; 11(2):188-194. PubMed ID: 33746443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity-Specific Differences in Liver Transplant Outcomes Among Adults With Primary Sclerosing Cholangitis: 2005-2017 United Network for Organ Sharing/Organ Procurement and Transplantation Network.
    Bayable A; Ohabughiro M; Cheung R; Wong RJ
    J Clin Exp Hepatol; 2021; 11(1):30-36. PubMed ID: 33679046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.
    Lim WH; Yong JN; Ong CEY; Ng CH; Tan DJH; Zeng RW; Chung CH; Kaewdech A; Chee D; Tseng M; Wijarnpreecha K; Syn N; Bonney GK; Kow A; Huang DQ; Noureddin M; Muthiah M; Tan E; Siddiqui MS
    Liver Transpl; 2023 Nov; 29(11):1181-1191. PubMed ID: 37039547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
    Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
    Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.
    Cholankeril G; Gonzalez HC; Satapathy SK; Gonzalez SA; Hu M; Khan MA; Yoo ER; Li AA; Kim D; Nair S; Wong RJ; Kwo PY; Harrison SA; Younossi ZM; Lindor KD; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Jun; 16(6):965-973.e2. PubMed ID: 29427734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.
    Mazur RD; Cron DC; Goldberg DS; Yeh H; Dageforde LA
    Clin Transplant; 2024 Jun; 38(6):e15365. PubMed ID: 38804605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
    Shirazi F; Wang J; Wong RJ
    J Clin Exp Hepatol; 2020; 10(1):30-36. PubMed ID: 32025164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Analysis of Liver Transplantation Outcomes Among Ethnic Minorities in the United States.
    Kaswala DH; Zhang J; Liu A; Sundaram V; Liu B; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2020 Mar; 54(3):263-270. PubMed ID: 31169758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    McCabe P; Galoosian A; Wong RJ
    Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy.
    Sundaram V; Shah P; Mahmud N; Lindenmeyer CC; Klein AS; Wong RJ; Karvellas CJ; K Asrani S; Jalan R
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1204-1213. PubMed ID: 32725664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation.
    Zhou K; Dodge JL; Xu E; Emamaullee J; Kahn JA
    Clin Transplant; 2022 Feb; 36(2):e14527. PubMed ID: 34731515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.